Harbor Capital Advisors, Inc. Legend Biotech Corp Transaction History
Harbor Capital Advisors, Inc.
- $2.38 Billion
- Q2 2025
A detailed history of Harbor Capital Advisors, Inc. transactions in Legend Biotech Corp stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 50,056 shares of LEGN stock, worth $1.98 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
50,056
Previous 39,537
26.61%
Holding current value
$1.98 Million
Previous $1.34 Million
32.44%
% of portfolio
0.07%
Previous 0.06%
Shares
9 transactions
Others Institutions Holding LEGN
# of Institutions
229Shares Held
74.4MCall Options Held
247KPut Options Held
406K-
Westfield Capital Management CO LP Boston, MA6.92MShares$273 Million1.21% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.73MShares$266 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$236 Million6.23% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$226 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.75MShares$148 Million5.57% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.61B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...